CONCEPTUS REPORTS NET LOSS OF $8.1 MILLION FOR 3RD QTR.(financial
data for Conceptus Inc.)
Conceptus, Inc. (NASDAQ:CPTS), San Carlos, Calif., developer of the
non-incisional permanent birth control procedure Essure(TM), has
announced financial results for the three and nine months . . .
WATERS REPORTS INCREASED THIRD QUARTER SALES.(Waters Corp.)(Brief
Article)
Waters Corporation (NYSE:WAT), Milford, Mass., has reported that
third quarter 2002 sales increased by 4% over prior year levels before
favorable currency effects. After currency effects, reported . . .
BONE CARE INTL. REPORTS INCREASED REVENUES FOR FIRST QTR.
Bone Care International, Inc. (NASDAQ: BCII), Middleton, Wis., has
announced that total revenues for the first quarter ended September 30,
2002 increased to $5.4 million from $2.6 million in the . . .
BIOSPHERE REPORTS 3RD QTR INCREASE IN CONSOLIDATED
REVENUES.(BioSphere Medical Inc.)
BioSphere Medical(TM), Inc. (Nasdaq: BSMD), Rockland, Mass., a
medical device company that is pioneering the use of bioengineered
microspheres to treat hypervascularized tumors and . . .
IDEXX REPORTS 3RD QTR NET INCOME INCREASED 22%.(IDEXX
Laboratories Inc.)
IDEXX Laboratories, Inc. (NASDAQ: IDXX), Westbrook, Maine, has
reported that net income increased 22% to $12.5 million, or $0.36 per
diluted share, for the quarter ended September 30, 2002, . . .
IMMUCELL RETURNS TO PROFITABILITY.
ImmuCell Corporation (NASDAQ: ICCC), Portland, Maine, has announced
a return to profitability and the results of its operations for the
three and nine month periods ended September 30, 2002.
. . .
PRAECIS REPORTS DECREASED NET LOSS FOR QUARTER.(Praecis
Pharmaceuticals Inc.)
Praecis Pharmceuticals, Inc. (NASDAQ: PRCS), Waltham, Mass., has
announced consolidated financial results for the three and nine months
ended September 30, 2002.
The company's net loss for the . . .
PANGEO PHARMA'S 2ND QTR EARNINGS BEFORE INCOME TAXES GROW
106%.(Brief Article)(Statistical Data Included)
PanGeo Pharma, Inc. (TSX:PIL.TO), Montreal, reports 14th
consecutive quarter of comparative net income margin growth
For the second quarter
-- Consolidated revenues for the quarter rise 56% to . . .
COOPER COMPANIES INC. REPORTS 3RD QTR REVENUE UP 48%.(Statistical
Data Included)
The Cooper Companies, Inc. (NYSE:COO), Lake Forest, Calif., has
reported financial results for its third fiscal quarter ended July 31,
2002:
-- Revenue $90.6 million, 48% above third quarter . . .
PRIMEDEX HEALTH SYSTEMS REPORTS 3RD QUARTER LOSS.(Brief
Article)(Statistical Data Included)
Primedex Health Systems, Inc., Los Angeles, Calif., (OTCBB:PMDX),
owner and operator of 52 California medical diagnostic imaging
facilities, has reported a third quarter loss of $5,122,000.
. . .
BIO REFERENCE LABS REPORTS RECORD NET INCOME/REVENUE.(Brief
Article)(Statistical Data Included)
Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) Elmwood Park, N.J,
has announced record net income of $1,504,321 or $.12 per share on a
fully diluted basis for the third quarter of fiscal year 2002 . . .
BIOTRANSPLANT REPORTS 2ND QTR '02 NET LOSS OF $24.08
MILLION.(Brief Article)(Statistical Data Included)
BioTransplant Incorporated (Nasdaq: BTRN), Charlestown, Mass., has
reported financial results for the second quarter and six- month period
ended June 30, 2002.
For the quarter ended June 30, . . .
INAMED REPORTS TOTAL SALES FOR 2ND QTR HIGHEST EVER.(Brief
Article)(Statistical Data Included)
Inamed Corporation (Nasdaq: IMDC), Santa Barbara, Calif., a global
medical device company, has announced final financial results for the
second quarter ended June 30, 2002. In addition, the company . . .
STELLAR INTERNATIONAL REVENUES/GROSS PROFITS MORE THAN
DOUBLE.(Brief Article)(Statistical Data Included)
Stellar International Inc. (TSXV:YYS), a Canadian pharmaceutical
developer and marketer of high-quality, cost- effective products for
select health care markets, has reported sharp revenue and . . .
MISONIX REPORTS LOWER REVENUES FOR FISCAL 2002.(Brief
Article)(Statistical Data Included)
Misonix Inc. (Nasdaq:MSON), Farmingdale, N.Y., has reported fiscal
results for the three and twelve months ended June 30, 2002. Highlights
for the fourth fiscal quarter include the completion of . . .
SONUS REPORTS $3.5 MILLION 2ND QTR 2002 NET LOSS.(Brief
Article)
Sonus Pharmaceuticals, Inc. (Nasdaq:SNUS), Bothell, Wash., has
announced financial results for the second quarter ended June 30, 2002.
The company also reported progress with its Phase 2 clinical . . .
GUIDANT REPORTS ALL-TIME RECORD SALES AND EARNINGS.(Brief
Article)
Guidant Corporation (NYSE:GDT) (PCX:GDT), Indianapolis, a world
leader in the treatment of cardiac and vascular disease, has reported
record quarterly sales of $807.0 million. Guidant achieved . . .
VIVUS REPORTS NET LOSS OF $3.3 MILLION FOR 2ND QTR
'02.(Brief Article)
VIVUS, Inc. (Nasdaq:VVUS), Mountain View, Calif., a pharmaceutical
company developing innovative products to improve quality of life, has
reported financial results for the three and six months . . .
ENZO BIOCHEM REPORTS INCREASED NET INCOME FOR FISCAL 3RD
QTR.
Enzo Biochem, Inc. (NYSE:ENZ), Farmingdale, N.Y., a leading
biotechnology company specializing in gene identification and gene
regulation technologies for diagnostic and therapeutic applications, . . .
INNOVATIVE MEDICAL SERVICES' 3RD QTR NET SALES INCREASED
25%.(Brief Article)
Innovative Medical Services (Nasdaq: PURE), San Diego, a
biosciences company that develops and markets technology-based products
involving water purification/treatment, pest control, and . . .
|
|